资讯

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, ...